United Health Products, Inc. UEEC
Rating
Rating Factors
Company Overview
United Health Products, Inc. operates in the healthcare and biomedical products sector, with a primary focus on hemostatic technologies used to control bleeding in surgical and wound-care settings. The company’s principal product platform is HemoStyp, a patented cellulose-based hemostatic gauze designed to absorb blood and assist in clot formation during medical procedures. The company has historically positioned itself within the broader medical device and surgical products industry, targeting hospitals, surgical centers, emergency care providers, and wound management applications.
The company evolved from earlier business activities into a healthcare-focused enterprise centered on intellectual property and commercialization of hemostatic products. Public disclosures indicate that United Health Products has concentrated much of its corporate strategy on regulatory pathways, patent protection, and commercialization planning associated with HemoStyp technology. Available public filings and disclosures indicate the company remains in a developmental and commercialization-focused stage relative to larger established medical device manufacturers.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $0.03
- Current
- $0.04
- High
- $0.12
Valuation
Dividends and Shares
Corporate Info
Suite D-406
Mount Laurel, NJ 08054